Johnson & Johnson MedTech Acquires Laminar, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St rises as yields ease, Moderna lifts healthcare stocks
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
Johnson & Johnson (JNJ) transition underway, UBS assesses upcoming analyst day
December 1, 2023 9:05 AM ESTUBS maintained Johnson & Johnson (NYSE: JNJ) at Buy with a $180 per share price target on Friday in its analyst day preview note.
The firm said it expects the company to reiterate its pharma guide, while its MedTech guide will at... More
